Male HPV vaccination rates soar with intensive QI project
BALTIMORE – A 3-year quality improvement (QI) measure succeeded in delivering the full human papillomavirus series to more than four out of five eligible boys.
The high rate of completed...
Source: Pediatric News - Category: Journals (General) Source Type: news
More News: Boys | Cervical Cancer Vaccine | General Medicine | Genital Warts | Human Papillomavirus (HPV) | Pediatrics | Vaccines